Literature DB >> 1428913

Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites.

S P Hume1, A A Lammertsma, C J Bench, V W Pike, C Pascali, J E Cremer, R J Dolan.   

Abstract

The biologically active S-enantiomer of [N-methyl-11C]citalopram was evaluated as a radioligand for in vivo labelling of the 5-hydroxytryptamine uptake site in brain, using ex vivo tissue counting in rats and positron emission tomography in man. In rats, the maximal signal for total versus non-specific binding was approx. 2 at 60-120 min after radioligand injection. Subsequent studies in man failed to identify a specific signal over a 90 min scanning period, due to prolonged retention of non-specific label.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428913     DOI: 10.1016/0883-2897(92)90171-t

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  1 in total

1.  Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.

Authors:  A K Larsen; L T Brennum; J Egebjerg; C Sánchez; C Halldin; P H Andersen
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.